MRI in liver cirrhosis

Review advocates streamlined, noninvasive pathways for cirrhosis assessment, replacing fragmented diagnostics and biopsies. LiverMultiScan cT1 is highlighted as a fast, fully noninvasive biomarker that can simplify clinical pathways, support diagnosis and screening of liver diseases, and reduce clinic burden.